Illumina to acquire Peninsula cancer detection biotech Grail in $8B deal

The agreement comes after Menlo Park-based Grail filed plans earlier in September to go public later in the year.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news